A senior DTCP official on Friday said that six teams have been deployed to paste show cause notices across these colonies ...
1h
Hosted on MSNPfizer’s Talzenna gains 14-months OS lead over mCRPC SoCResults from the company’s Talapro-2 trial saw a 38% reduction in the risk of death among HRR-mutated patients.
A multi-year project featuring Improvements to the Emergency Department at MyMichigan Medical Center in Midland are underway.
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
A phase 2 study evaluated the use of ruxolitinib plus standard GVHD prophylaxis in patients with myelofibrosis undergoing ...
The FaZe Clan streamers were left outraged after two bystanders began throwing fries at them and insulting the group.
The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
Residents who lost their homes in the Palisades and Eaton fires can now sign up for toxic debris removal on the county's website.
Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Crypto analysts suggest that the altcoin market is still in an early “speculative” phase before staging a recovery to 2021 ...
Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...
Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results